Novasep Announces the Launch of a Consent Solicitation for the Maturity Extension of Notes with Requisite Voting Majority of the Noteholders Already Secured

Lyon, France (ots/PRNewswire) -

Novasep Holding S.A.S ("Novasep"), a leading supplier of services
and technologies for the life sciences industry, announces the launch
of a consent solicitation (the "Consent Solicitation") in order to,
inter alia :

- extend the maturity of the senior notes in an initial aggregate
principal amount of EUR 181,718,112 due May 31, 2019 issued on
November 3, 2016 by Novasep (ISIN: FR0013213568, Common Code
151496652) (the "Notes") to May 31, 2022 (the "Notes Maturity
Extension"),
- in line with the Notes Maturity Extension, extend the maturity of
the C warrants expiring on May 31, 2019 issued by Novasep on
November 3, 2016 (ISIN FR0013213576, Common Code 151497047) (the "C
Warrants") to May 31, 2022 (the "C Warrants Maturity Extension"),
- approve the waiver of certain conditions of the terms and
conditions of the Notes, amend certain terms and conditions of the
Notes and C Warrants and appoint DIIS Group as new representative
("Représentant de la masse") of the holders of Notes (the "
Noteholders") and of the holders of C Warrants (the "C
Warrantholders"), all as detailed in a consent solicitation
memorandum dated January 31, 2019 prepared by Novasep in connection
with the Consent Solicitation (the "Consent Solicitation Memorandum
").

(Logo: https://mma.prnewswire.com/media/815661/Novasep_Logo.jpg )

Novasep is convening a general meeting of the Noteholders (the
"Noteholders' General Meeting") and of the C Warrantholders (the "C
Warrantholders' General Meeting") on February 19, 2019 at Novasep's
registered office to approve the foregoing, as described in the
Consent Solicitation Memorandum.

The completion of the Notes Maturity Extension and the
implementation of the other resolutions described above will
contribute to Novasep's achievement of its ambitious growth plan and
development.

If the resolutions are approved by the Noteholders General
Meeting, all the Noteholders will receive, as a consent fee, their
respective pro rata shares of a global amount in cash of 1.00% of the
aggregate initial principal amount of the Notes (i.e.
EUR1,817,181.12).

Holders of the Notes and C Warrants holding in aggregate more than
66.7% of the outstanding principal amount of the Notes and more than
66.7% of the total number of outstanding C Warrants have already
agreed to attend the Noteholders' General Meeting and the C
Warrantholders' General Meeting and vote in favor of both the Notes
Maturity Extension and the C Warrants Maturity Extension. Therefore,
Novasep expects that the quorum and voting majority required to adopt
the Notes Maturity Extension and all the other resolutions described
above will be achieved at the Noteholders General Meeting.

The Noteholders and the C Warrantholders convening notices (in
French and English), the text of the resolutions proposed to each of
the Noteholders and the C Warrantholders (in French and English),
the report of the President of Novasep on the proposed resolutions
presented to each of the Noteholders General Meeting and C
Warrantholders General Meeting (in French and English), the amended
and restated Terms and Conditions of the Notes (in French and English
), the amended and restated Terms and Conditions of the C Warrants
(in French and English) and the Consent Solicitation Memorandum are
available pursuant to applicable laws and regulations, upon
request, (i) at the registered office of Novasep located at
Boulevard de la Moselle, Site Eiffel, 54340 Pompey (France) and (ii)
at the specified office of Société Générale, acting as centralizing
agent, 32, rue du Champ de Tir CS 30812 44308 Nantes Cedex 3 France
(Phone + 33 2 51 85 65 93 - agobligataire.fr@socgen.com).

The Consent Solicitation Memorandum is also available to the
Noteholders and C Warrantholders on Novasep's website
(http://www.novasep.com) in the Investors section. For more details
on the availability of the above-mentioned documents and
participation and voting forms please see the Consent Solicitation
Memorandum.

About Novasep

Novasep is a global provider of cost-effective and sustainable
manufacturing solutions for life sciences molecules and fine
chemicals. Novasep's unique offering includes process development
services, purification equipment and turnkey processes, contract
manufacturing services and complex active molecules to serve
pharmaceutical, biopharmaceutical, fine chemical, food and functional
ingredients as well as fermentation and chemical commodities
industries.

http://www.novasep.com

Disclaimer

This press release is not an offer of securities for sale or a
solicitation of an offer to purchase securities in the United States
or any other jurisdiction. The securities referred to herein have not
been and will not be registered under the US Securities Act of 1933,
as amended (the "Securities Act") and may not be offered and sold in
the United States absent registration or an applicable exemption from
the registration requirements of the Securities Act.

The distribution of this press release in certain jurisdictions
may be restricted by law.

ots Originaltext: Novasep
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Laure Saloin
Communication Project Manager - Corporate Branding & Social Media
laure.saloin@novasep.com
+33 (0)7 77 94 37 52

Original-Content von: Novasep, übermittelt durch news aktuell